Cargando…
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362
[Image: see text] Plasmepsin X (PMX) is an essential aspartyl protease controlling malaria parasite egress and invasion of erythrocytes, development of functional liver merozoites (prophylactic activity), and blocking transmission to mosquitoes, making it a potential multistage drug target. We repor...
Ejemplares similares
-
Phosphoprotein expression profiles in rat kidney injury: Source for potential mechanistic biomarkers
por: Gryshkova, Vitalina, et al.
Publicado: (2019) -
Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies
por: Delaunois, Annie, et al.
Publicado: (2021) -
Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X
por: Li, Fengwu, et al.
Publicado: (2016) -
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
por: Richardson, Lachlan W., et al.
Publicado: (2022) -
Macrocyclic
Peptidomimetic Plasmepsin X Inhibitors
with Potent In Vitro and In Vivo Antimalarial Activity
por: Kovada, Vadims, et al.
Publicado: (2023)